|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.89 CNY | +2.23% |
|
-0.94% | -8.40% |
| 06-09 | China Approves Aodong Subsidiary's Levocarnitine Injection | MT |
| 05-21 | Jilin Aodong Pharmaceutical Gets China Approval for Supplemental Registration of Heart Drug | MT |
| Market Cap | 20.97B 3.1B 2.71B 2.5B 2.31B 4.35B 297B 4.43B 29.83B 11.71B 146B 11.63B 11.37B 502B | P/E 2024 |
13.1x | P/E 2025 | 9.57x |
|---|---|---|---|---|---|
| Enterprise Value | 20.25B 2.99B 2.61B 2.42B 2.23B 4.2B 287B 4.28B 28.8B 11.3B 141B 11.23B 10.98B 484B | EV / Sales 2024 |
7.76x | EV / Sales 2025 | 9.49x |
| Free-Float |
67.59% | Yield 2024 |
2.9% | Yield 2025 | 2.56% |
| 1 day | +2.23% | ||
| 1 week | -0.94% | ||
| Current month | +0.90% | ||
| 1 month | +2.88% | ||
| 3 months | -2.40% | ||
| 6 months | -11.39% | ||
| Current year | -8.40% |
| 1 week | 17.27 |  | 17.93 |
| 1 month | 17.08 | | 18.88 |
| Current year | 16.36 | | 20.93 |
| 1 year | 16.36 | | 22.08 |
| 3 years | 12.49 | | 22.08 |
| 5 years | 12.49 | | 22.08 |
| 10 years | 12.49 | | 29.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 63 | 2017-07-16 |
Kai Yang
DFI | Director of Finance/CFO | 49 | 2004-04-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 54 | 2007-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Lin Li
CHM | Chairman | 73 | 2005-05-17 |
Shu Qin Guo
BRD | Director/Board Member | 63 | 2000-01-31 |
Yong Feng Chen
CHM | Chairman | 59 | 2017-07-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-24 | Buy | 100 | 0.0000% | |||
| 24-07-28 | Buy | Chief Executive Officer | 320,000 | 0.0276% | ||
| 24-07-28 | Buy | Chairman | 350,000 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.23% | -0.94% | -3.04% | +10.50% | 3.1B | |
| -2.48% | -6.72% | +44.19% | +156.43% | 1,028B | |
| -1.52% | -5.01% | +61.87% | +58.79% | 611B | |
| -1.30% | -3.88% | +27.81% | +79.97% | 432B | |
| -1.12% | -3.68% | +26.89% | +20.58% | 323B | |
| -1.73% | -3.45% | +26.95% | +44.09% | 277B | |
| -1.95% | -13.92% | +15.96% | +19.76% | 257B | |
| -1.45% | -2.37% | -27.87% | -39.87% | 217B | |
| -1.44% | -3.49% | +19.60% | +56.20% | 192B | |
| -1.04% | -4.63% | +16.01% | +68.47% | 161B | |
| Average | -0.89% | -3.63% | +20.84% | +47.49% | 350.14B | |
| Weighted average by Cap. | -0.90% | -4.75% | +33.07% | +76.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.61B 385M 337M 311M 288M 542M 37.02B 552M 3.71B 1.46B 18.13B 1.45B 1.42B 62.42B | 2.34B 345M 301M 279M 257M 485M 33.12B 493M 3.32B 1.3B 16.22B 1.3B 1.27B 55.84B |
| Net income | 1.55B 229M 200M 185M 171M 322M 22B 328M 2.21B 866M 10.77B 860M 841M 37.1B | 2.4B 354M 309M 286M 264M 497M 33.97B 506M 3.41B 1.34B 16.63B 1.33B 1.3B 57.27B |
| Net Debt | -386M -56.99M -49.8M -46.04M -42.53M -80.1M -5.47B -81.55M -549M -215M -2.68B -214M -209M -9.23B | -724M -107M -93.42M -86.36M -79.78M -150M -10.27B -153M -1.03B -404M -5.03B -402M -393M -17.31B |
Employees
5,461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | CN¥17.89 | +2.23% | 15,633,702 |
| 26-07-13 | CN¥17.50 | -0.79% | 12,861,097 |
| 26-07-10 | CN¥17.64 | -1.07% | 14,006,300 |
| 26-07-09 | CN¥17.83 | +0.73% | 12,360,059 |
| 26-07-08 | CN¥17.70 | -1.99% | 10,420,598 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 000623 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
